Research Article
Renal and Inflammatory Proteins as Biomarkers of Diabetic Kidney Disease and Lupus Nephritis
Table 3
Sensitivity and specificity.
(a) |
| Control vs. DKD | Biomarker | Cut-off point (pg/ml) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Likelihood ratio | Accuracy (%) |
| ASC | >632 | 89 | 63 | 61 | 90 | 2.400 | 73 | IL-18 | >268.7 | 74 | 53 | 53 | 74 | 1.595 | 62 | CRP | > 2,984,567 | 61 | 51 | 42 | 69 | 1.249 | 55 | uPA | > 875 | 70 | 57 | 58 | 68 | 1.610 | 63 | EGF | > 27.99 | 100 | 94 | 95 | 100 | 17.00 | 97 | Lipocalin-2 | > 10,187 | 100 | 83 | 78 | 100 | 6.00 | 89 |
|
|
(b) |
| Control vs. LN | Biomarker | Cut-off point (pg/ml) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Likelihood ratio | Accuracy (%) |
| ASC | > 521.6 | 63 | 53 | 50 | 66 | 1.344 | 57 | IL-18 | > 278.9 | 78 | 58 | 58 | 78 | 1.866 | 67 | CRP | > 3,768,714 | 66 | 62 | 56 | 71 | 1.703 | 63 | uPA | > 890.3 | 84 | 65 | 72 | 79 | 2.415 | 75 | EGF | > 38.53 | 100 | 100 | 100 | 100 | ā | 100 | Lipocalin-2 | > 10,516 | 88 | 83 | 79 | 91 | 5.294 | 85 |
|
|